SCHEMBL19080096

SCHEMBL19080096

c1ccc2cc(-c3c4ccccc4c(-c4ccc5cc(-c6cc7oc8cc9ccccc9cc8c7c7ccccc67)ccc5c4)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
MIF P14174 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
PRKDC P78527 1/20 0.34
ESR2 Q92731 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALOX5 P09917 2/20 0.33
ESR1 P03372 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079984 0.96 GPR84 (0.36) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19080033 0.94 ESR1 (0.40) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL20127351 0.91 GPR84 (0.40) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL20127360 0.91 GSTP1 (0.40) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19080062 0.91 PSD (0.34) GPR84HDAC4HDAC2HDAC8CYP1A1
SCHEMBL19080080 0.91 GPR84 (0.35) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19076513 0.91 AHR (0.39) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19076496 0.89 MAOA (0.38) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL20127349 0.88 MAPT (0.39) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19076388 0.87 AHR (0.36) GSTP1GPR84MIFHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 GSTP1 1966/4885GPR84 2425/4885MIF 2417/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GSTP1 1966/4885GPR84 2425/4885MIF 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.